期刊文献+

基因变异及心血管危险因素与单核细胞分泌白细胞介素6和10的关系 被引量:2

Relationship of genetic variants and cardiovascular risk factors with interleukin-6 and interleukin-10 secreted by monocytes
下载PDF
导出
摘要 目的:研究白细胞介素(interleukin,IL)-6、IL-10基因变异及心血管危险因素[包括氧化低密度脂蛋白(oxygenized low density lipoprotein,ox-LDL)、缺乏体力活动、超重等]与单核细胞分泌IL-6和IL-10的关系.方法:2010年在北京社区人群随机抽取无心肌梗死和脑卒中病史的40名51 ~80岁的健康人,收集吸烟、饮酒资料,测量血压、空腹血糖、血脂等心血管危险因素指标,并检测IL-6(rs1800796、rs1524107、rs2066992)、IL-10基因变异(rs1800872、rs1554286、rs3021094).分离静脉血单核细胞,在RPMI 1640培养液中培养24 h,分为二等份,一份加入ox-LDL(50 mg/L)刺激,另一份加入磷酸盐缓冲液(PBS)对照,继续培养48 h,采用ELISA法检测上清液IL-6和IL-10的浓度.结果:配对Wilcoxon检验显示,与PBS培养液相比,ox-LDL培养液中单核细胞分泌IL-6、IL-10以及IL-6/IL-10显著升高(P<0.01).以PBS和ox-LDL培养液中IL浓度作为重复测量结果,调整年龄、性别后,重复测量的多因素一般线性模型显示,超重者(BMI≥26 kg/m2)单核细胞分泌IL-10显著低于体重较轻者(P =0.007),IL-6/IL-10则显著高于体重较低者(P=0.003);缺乏体力活动者[metabolic equivalent of energy,METS< 166 kJ/(kg·d)]单核细胞分泌的IL-6/IL-10显著高于体力活动较高者(P=0.046);饮酒者单核细胞分泌的IL-6和IL-10显著高于不饮酒者(P =0.049和0.006);高密度脂蛋白胆固醇(high-density lipoprotein-eholesterol,HDL-c)较高者(≥56.4 mg/dL)单核细胞分泌IL-6显著升高(P=0.027);IL-10的3个单核苷酸多态性(single nucleotide polymorphism,SNP)位点(rs1800872、rs1554286、rs3021094)与ox-LDL对单核细胞分泌IL-10存在显著交互作用(P<0.05),IL-6基因SNP与ox-LDL无显著交互作用.结论:ox-LDL、缺乏体力活动、超重等心血管因素与炎症-抗炎平衡向炎症方向偏斜密切相关,IL-10基因和ox-LDL的交互作用与抗炎细胞因子IL-10表达密切相关. Objective:To examine the relationship of interleukin (IL)-6 and IL-10 genetic variants and cardiovascular factors [ oxygenized low density lipoprotein (ox-LDL), lower physical activity, over- weight, etc. ] with IL-6 and IL-10 secreted by monocytes. Methods: In the study, 40 health persons, aged from 51 to 80 years, without stroke and myocardial infarction, were randomly sampled from a com- munity-based population in Beijing in 2010. Their data on smoking, drinking, blood pressure, fasting glucose, and lipid were collected. The single nucleotide polymorphisms (SNPs) of IL-6 (rs1800796, rs1524107, rs2066992) and IL-10 (rs1800872, rs1554286, rs3021094) were genotyped. The human monocytes were cultivated in RPMI 1640 medium for 24 h; then divided into two equal parts, in which ox-LDL (50 mg/L) and phosphate buffer solution (PBS) were added for another 48 h. Finally, the se- cretions of IL-6 and IL-10 in the culture supernatants were measured with ELISA. Results: Paired Wilcoxon tests showed that the IL-6, IL-10, and IL-6/IL-10 were significantly higher in ox-LDL medium than in PBS one (all P 〈 0.01 ). The concentrations in PBS/ox-LDL taken as repeated measurements, and adjusted for age and gender, the repeated general linear models showed: IL-10 was significantly lower for those overweight (BMI〉~26 kg/m2) than for those normal weight (P = 0. 007 ), and IL-6/IL- 10 was significantly higher in those overweight (P =0.003 ). The IL-6/IL-10 was significantly higher in those with lower physical activity [ metabolic equivalent of energy, METS 〈 166 kJ/( kg · d) ] than those with higher physical activities (P =0. 046). IL-6 and IL-10 were significantly higher in alcohol drinkers ( P = 0. 049 and P = 0.006). IL-6 was significantly higher in those with higher high-density lipoprotein- cholesterol (HDL-c, i〉 56.4 mg/dL, P = 0. 027 ). There were significant interactions between IL-10 SNPs and ox-LDL on IL-10 (all P 〈 0.05 ), but no significant interactions between IL-6 gene SNPs and ox-LDL on IL-6. Conclusion: The ox-LDL together with lower physical activity and overweight shifts the balance of pro-inflammatory and anti-inflammatory in the direction of pro-inflammatory. The interaction between IL-10 gene and ox-LDL is intensively correlated with the secretion of the anti-inflammatory cyto- kine IL-10.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2014年第4期589-595,共7页 Journal of Peking University:Health Sciences
基金 国家自然科学基金(30872168)资助~~
关键词 白细胞介素-6 白细胞介素-10 变异(遗传学) 运动活动 超重 Interleukin-6 Interleukin-lO Variation (genetics) Motor activity Overweight
  • 相关文献

参考文献19

  • 1卫生部心血管病防治研究中心.中国心血管病报告2011[R].北京:中国大百科全书出版社,2012: 91 -94.
  • 2Ross R.Atherosclerosis-an inflammatory disease[J].N Engl J Med,1999,340(2):115-126.
  • 3Kitamura A,Hasegawa G,Obayashi H,et al.Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes[J].Diabet Med,2002,19(12):1000-1005.
  • 4Ying B,Shi Y,Pan X,et al.Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis[J].Mol Biol Rep,2011,38(1):379-385.
  • 5Xie G,Myint PK,Zhao L,et al.Relationship between-592A/C polymorphisms of interleukin-10 (IL-10) gene and risk of early carotid atherosclerosis[J].Int J Cardiol,2010,143(1):102-104.
  • 6Chen C,Lu FC,Department of Disease Control Ministry of Health,PR China.Guidelines for prevention and control of overweight and obesity in Chinese adults[J].Biomed Environ Sci,2004,17(suppl):1-36.
  • 7Vila N,Castillo J,Davalos A,et al.Proinflammatory cytokines and early neurological worsening in ischemic stroke[J].Stroke,2000,31 (10):2325-2329.
  • 8Yamagami H,Kitagawa K,Nagai Y,et al.Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques[J].Stroke,2004,35(3):677-681.
  • 9Mallat Z,Besnard S,Duriez M,et al.Protective role of interleukin-10 in atherosclerosis[J].Circ Res,1999,85(8):e17-24.
  • 10Smith JK,Dykes R,Douglas JE,et al.Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease[J].JAMA,1999,281 (18):1722-1727.

二级参考文献23

  • 1Danowski A, Kickler TS, Petri M. Anti-β2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus [ J ]. J Rheumatol, 2006,33 ( 9 ) : 1775-1779.
  • 2Lopez LR, Hurley BL, Simpson DF, et al. Oxidized low-density lipoprotein/β2- glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus[ J]. Ann N Y Acad Sci, 2005,1051 : 97 -103.
  • 3Marsuura E, Kobayashi K, Koike T, et al. Atherogenic autoantigen: oxidized LDL complexes with β2-glycoprotein I [ J ]. lmmunobiol, 2003, 207( 1 ) :17-22.
  • 4Finlayson JS, Mushinski JF. Separation of subfractions of human β2- glycoprotein I [ J ]. Biochim Biophys Acta, 1967, 147 ( 3 ) : 413-420.
  • 5Nilsson J, Bengtsson E, Fredrikson GN, et al. Inflammation and imnmnity in diabetic vascular complications[ J]. Curr Opin Lipidol, 2008,19:519-524.
  • 6Bassi N, Ghirardello A, Iaccarino L, et al. ox-LDL/132-GPI-anti- ox-LDL/β2-GPI complex and atherosclerosis in SLE patients [ J ]. Autoimmun Rev, 2007,7( 1 ) :52-58.
  • 7World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation .Geneva[ S]. World Health Organization, 2000( Technical Report Series, No. 894).
  • 8Esposito K, Giugliano G, Scuderi N, et al. Role of adipokines in the obesity-inflammation relationship:the effect of fat removal [ J], Plast Reconslr Surg,2006,118(4) : 1048 - 1057.
  • 9Mohamed AV, Goodrlek S, Rawesb A, et al. Subcutaneous adipose tissue releases interleukin-6 but not tumor necrosis factor-a, in vivo[J]. J Clin Endoerinol Metab, 1997,82(12) :4196 - 4200.
  • 10Hrnciar J, Gabor D, Hrnciarova M, et al. Relation between eytokines(TNF- α,IL-1 and 6)and homocysteine in android obesity and the phe-nomenon of insulin resistance syndromes[ J]. Vnitr lek, 1999,45 ( 1 ) : 11 - 16.

共引文献21

同被引文献16

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部